21.218 articles found

Therapeutic dilemma: psychosis and Parkinson's disease.

Damecour CL, Turcotte JR.

Can J Psychiatry · 1995-12-01

DOI: 10.1177/070674379504001020PMID: 8681265

[Levodopa-induced dyskinesia in 176 patients with Parkinson's disease].

Rocha MS, Andrade LA, Ferraz HB, Borges V.

Arq Neuropsiquiatr · 1995-12-01

DOI: 10.1590/s0004-282x1995000500004PMID: 8729765

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.

Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K.

Eur J Pharmacol · 1995-12-01

DOI: 10.1016/0014-2999(95)00594-3PMID: 8750721

Comparison of two forms of intensive speech treatment for Parkinson disease.

Ramig LO, Countryman S, Thompson LL, Horii Y.

J Speech Hear Res · 1995-12-01

DOI: 10.1044/jshr.3806.1232PMID: 8747817

Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients.

Mizutani Y, Okada Y, Ogawa M, Hasegawa T, Nabeshima T.

Biol Pharm Bull · 1995-12-01

DOI: 10.1248/bpb.18.1729PMID: 8787797

Levodopa Dependence and Hypersexuality in an Older Parkinson's Disease Patient.

Weinman E, Ruskin PE.

Am J Geriatr Psychiatry · 1995-12-01

DOI: 10.1097/00019442-199524310-00011PMID: 28530963

Use of creatine or creatine analogs for the treatment of diseases of the nervous system

KADDURAH-DAOUK RIMA, DAOUK GHALEB.

· 1995-11-07

Charcot as therapeutic interventionist and treating neurologist.

Goetz CG, Bonduelle M.

Neurology · 1995-11-01

DOI: 10.1212/wnl.45.11.2102PMID: 7501168

Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment.

Harrison J, Henderson L, Kennard C.

J Neurol Neurosurg Psychiatry · 1995-11-01

DOI: 10.1136/jnnp.59.5.499PMID: 8530934

Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series.

Madhusoodanan S, Brenner R, Araujo L, Abaza A.

J Clin Psychiatry · 1995-11-01

PMID: 7592504

The effect of deprenyl and levodopa on the progression of Parkinson's disease.

Olanow CW, Hauser RA, Gauger L, Malapira T, Koller W, Hubble J, Bushenbark K, Lilienfeld D, Esterlitz J.

Ann Neurol · 1995-11-01

DOI: 10.1002/ana.410380512PMID: 7486869

Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA-lipofectin complex.

Cao L, Zheng ZC, Zhao YC, Jiang ZH, Liu ZG, Chen SD, Zhou CF, Liu XY.

Hum Gene Ther · 1995-11-01

DOI: 10.1089/hum.1995.6.11-1497PMID: 8573622